Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

9:54 AM ET 10-Q
Financial Results Federal Home Loan Bank of Pittsburgh

Federal Home Loan Bank of Pittsburgh Q3 2026 Results: Revenue $1.24B, Up 24.2% YoY

Federal Home Loan Bank of Pittsburgh reported a significant increase in total assets to $126.0 billion as of September 30, 2026, driven primarily by a $50.2 billion growth in advances. Noninterest income improved significantly due to valuation gains in the economic derivative portfolio, while total other expenses decreased due to lower regulatory assessments and voluntary contributions.

9:54 AM ET 8-K
Loan & Debt Federal Home Loan Bank of Atlanta

Federal Home Loan Bank of Atlanta $1.11B Debt Financing

Federal Home Loan Bank of Atlanta committed to issue $1.115 billion in consolidated obligation bonds across five tranches between October 28 and October 29, 2026. These debt securities are the joint and several obligations of the eleven Federal Home Loan Banks and are used to fund the Bank's operations. The issuances include both fixed-rate bonds with maturities up to 2031 and variable-rate floaters maturing in early 2027.

Value
$1.11B
9:53 AM ET Form 4
Insider Selling Cullen/Frost Bankers, Inc. CFR

Cullen/Frost Bankers CAO Matthew Bradley Henson Sells $85.3K of Stock

Matthew Bradley Henson, CAO, sold 534 shares of Cullen/Frost Bankers, Inc. at $159.72 a share, worth $85.3K in total on Nov 2, 2026. Shares held after the trade: 317 (-62.7%).

Value
$85.3K
Shares
534
Price
$159.72
Role
CAO
Holding change
-62.7%
Trade date
Nov 2, 2026
9:50 AM ET 8-K/A
M&A Deal Hawthorn Bancshares, Inc. HWBK

Hawthorn Bancshares M&A Deal with FSC Bancshares, Inc.

Hawthorn Bancshares, Inc. filed an amendment to its previous 8-K to provide required financial statements and pro forma information following the completion of its acquisition of FSC Bancshares, Inc. The acquisition was effective as of September 3, 2026, and this filing includes audited 2025 financial statements for the acquired entity.

Counterparty
FSC Bancshares, Inc.
9:49 AM ET 8-K
Loan & Debt Weis Markets Inc WMK

Weis Markets $30M Debt Financing with Wells Fargo Bank, National Association

Weis Markets, Inc. entered into an amendment to its revolving credit agreement with Wells Fargo Bank, extending the maturity date to October 1, 2030. The agreement provides for an unsecured revolving credit facility of $30 million with an additional $70 million in discretionary availability. Interest on outstanding balances is set at Daily Simple SOFR plus 1.00%.

Value
$30M
Counterparty
Wells Fargo Bank, National Association
Term
through Oct 2030
9:45 AM ET 8-K
Dividend Main Street Capital Corp MAIN

Main Street Capital Dividend

Main Street Capital declared regular monthly dividends of $0.27 per share for Q1 2027, representing a 1.9% increase over the prior quarter. Additionally, the board declared a supplemental cash dividend of $0.30 per share payable in December 2026 from undistributed taxable income.

Term
Q1 2027
9:42 AM ET Form 4
Insider Buying First Financial Bankshares Inc FFIN

First Financial Bankshares Director Murray Hamilton Edwards Buys $15.3K of Stock

Murray Hamilton Edwards, Director, bought 500 shares of First Financial Bankshares Inc at $30.51 a share, worth $15.3K in total on Oct 30, 2026. Shares held after the trade: 45,434 (+1.1%).

Value
$15.3K
Shares
500
Price
$30.51
Role
Director
Holding change
+1.1%
Trade date
Oct 30, 2026
9:41 AM ET 8-K
Loan & Debt Federal Home Loan Bank of Pittsburgh

Federal Home Loan Bank of Pittsburgh $1.72B Debt Financing

Federal Home Loan Bank of Pittsburgh reported the issuance of consolidated obligation bonds and discount notes totaling approximately $1.715 billion in par value. These debt securities are joint and several obligations of the eleven Federal Home Loan Banks and are used to fund the bank's operations. The reported obligations include various fixed and variable rate instruments with maturities ranging from 2027 to 2046.

Value
$1.72B
9:41 AM ET 8-K
Financial Results Core Molding Technologies Inc CMT

Core Molding Technologies Financial Results

Core Molding Technologies reported Q3 2026 financial results, highlighted by a 19.7% increase in product revenue driven by heavy-duty truck demand and new program launches. Profitability was impacted by one-time commissioning costs for the Monterrey, Mexico expansion and footprint optimization activities. The company reaffirmed its full-year guidance for net sales to be flat to up 5% with gross margins between 16% and 17%.

Term
Q3 2026

“Our third quarter results reflect continued progress against our strategic initiatives that will shape our next phase of growth. While the quarter absorbed several one-time start-up costs associated with our Mexico expansion, footprint optimization, and higher external input costs, we achieved key operational milestones that position us for improved performance.”

Eric Palomaki, the Company’s President and Chief Executive Officer

“Third quarter financial results reflected strong underlying business activity and continued execution of our strategic growth investments. Product revenue increased nearly 20% year-over-year, driven by improving heavy-duty truck demand, new program launches, and continued strength in our building products and industrial and utilities end markets.”

Alex Panda, the Company’s EVP and Chief Financial Officer
9:34 AM ET Form 4
Insider Buying Constellium SE CSTM

Constellium Insider Jean-Christophe Deslarzes Buys $42.1K of Stock

Jean-Christophe Deslarzes bought 1,800 shares of Constellium SE at $23.41 a share, worth $42.1K in total on Nov 2, 2026. Shares held after the trade: 45,315 (+4.1%).

Value
$42.1K
Shares
1,800
Price
$23.41
Holding change
+4.1%
Trade date
Nov 2, 2026
9:33 AM ET 10-Q
Financial Results Newbridge Acquisition Ltd NBRG

Newbridge Acquisition Q3 2026 Results: Turns Profitable, Net Income $339K

Newbridge Acquisition Limited completed its Initial Public Offering on February 2, 2026, raising $57.5 million in gross proceeds. For the nine months ended September 30, 2026, the company reported a net income of $724,582, primarily driven by $1,281,228 in interest income earned on cash held in the Trust Account, offsetting $556,646 in operating expenses.

Key figure
Net income $339K
9:32 AM ET 6-K
Financial Results Fresenius Medical Care AG FMS

Fresenius Medical Care Q3 2026 Results: Net Income $225M, Down 31.3% YoY

Fresenius Medical Care AG reported its interim financial results for the third quarter of 2026, highlighting a reorganization of its pharmaceutical business from the Care Enablement segment to the Care Delivery segment. The report also notes the integration of administrative functions for the Value-Based Care segment into global functional areas and the ongoing implementation of a new enterprise resource planning software.

Key figure
Net income $225M · -31.3% YoY
9:32 AM ET 8-K
Financial Results Syra Health Corp SYRA

Syra Health Financial Results

Syra Health reported its third consecutive profitable quarter with record revenue of $2.6 million, a 52% increase year-over-year. The company achieved a record gross margin of 46.3% and positive net income of $0.34 million, compared to a loss in the prior year period.

Term
Q3 2026
9:28 AM ET 10-Q
Financial Results Beta Technologies, Inc. BETA ▶ Call

Beta Technologies Q3 2026 Results: Net Loss of $119M, Loss Narrows

BETA Technologies, Inc. reported a total asset base of $1.86 billion as of September 30, 2026, down from $2.11 billion at the end of 2025, primarily driven by a decrease in cash and cash equivalents. The company's accumulated deficit increased to $2.30 billion, reflecting a net loss of approximately $390 million for the first nine months of the year as it continues to invest in aircraft certification and manufacturing.

Key figure
Net loss $119M
9:25 AM ET 8-K
Financial Results Zebra Technologies Corp ZBRA

Zebra Technologies Financial Results

Zebra Technologies reported record third-quarter 2026 results with net sales increasing 22.3% to $1.61 billion, driven by strong demand for automation and the contribution of the Elo Touch acquisition. The company achieved a net income of $164 million and raised its full-year outlook while returning $75 million to shareholders through stock repurchases during the quarter.

Term
Q3 2026

“We delivered another record quarter underpinned by strong execution and broad-based demand trends with Elo Touch contributing to our double-digit growth as customers prioritize automating their frontline operations. Our efforts to strengthen memory supply, implement pricing actions and capture operating leverage enabled us to support our growth while maintaining adjusted EBITDA margin year-over-year.”

Bill Burns, Chief Executive Officer of Zebra Technologies

“We are putting our strong cash generation and balance sheet to work, investing in growth while returning capital to shareholders. We repurchased more than $640 million of shares through the first nine months of the year, reflecting our confidence in Zebra's long-term opportunity and our commitment to disciplined capital allocation.”

Nathan Winters, Chief Financial Officer of Zebra Technologies
9:22 AM ET 10-Q
Financial Results Alkermes plc. ALKS

Alkermes Q3 2026 Results: Net Income $16.3M, Down 80.3% YoY

Alkermes plc reported a significant increase in cash and cash equivalents to $631.3 million as of September 30, 2026, compared to $388.6 million at year-end 2025. The company's intangible assets grew substantially from $0.8 million to over $1.74 billion, reflecting the impact of the Avadel Acquisition and its expanded neuroscience portfolio including LUMRYZ.

Key figure
Net income $16.3M · -80.3% YoY
9:18 AM ET 8-K
Financial Results Otter Tail Corp OTTR

Otter Tail Financial Results

Otter Tail Corporation reported Q3 2026 diluted earnings per share of $1.41 and narrowed its full-year earnings guidance. The company also declared a quarterly common stock dividend of $0.5775 per share and noted that its Electric segment is advancing solar and wind repowering projects.

Term
Q3 2026

“Our team members continue to deliver on our strategic growth plan and near-term priorities amidst a challenging operating environment.”

Chuck MacFarlane, CEO

“The fundamentals of our diversified portfolio remain strong, and we are confident in our ability to deliver on our strategic growth plan over the long-term.”

Chuck MacFarlane, CEO
9:16 AM ET 8-K
Financial Results Fusemachines Inc. FUSE

Fusemachines Financial Results

Fusemachines Inc. reported Q3 2026 financial results featuring a 2.8% quarter-over-quarter revenue increase to $1.85 million and a 39.2% improvement in Adjusted EBITDA loss. Despite operational improvements from cost-reduction initiatives, the company reported a GAAP net loss of $4.6 million and disclosed substantial doubt about its ability to continue as a going concern.

Term
Q3 2026

“Our 39.2% quarter-over-quarter improvement in our Adjusted EBITDA demonstrates the meaningful progress we are making in improving the financial and operational performance of Fusemachines. Our cost-reduction initiatives are delivering measurable results, allowing us to significantly reduce operating losses while continuing to grow revenue. We remain focused on building a more efficient operating structure, strengthening our financial position, and advancing our enterprise AI business.”

Sameer Maskey, Founder and Chief Executive Officer of Fusemachines
9:15 AM ET 8-K
M&A Deal Impact Biomedical Inc. IBO

Impact Biomedical M&A Deal with Zoar Limited

Impact Biomedical Inc. announced that the SEC has declared effective the Form F-4 registration statement for its proposed merger with Zoar Limited. A special meeting of stockholders to approve the business combination is scheduled for November 13, 2026, with the combined company expected to trade under the ticker symbol 'ZOAR'.

Counterparty
Zoar Limited
9:15 AM ET 8-K
Financial Results BayFirst Financial Corp. BAFN

BayFirst Financial Financial Results

BayFirst Financial Corp. reported a net loss of $677 thousand for the third quarter of 2026, a significant improvement from the $32.7 million loss in the prior quarter. The company saw community bank loans grow by 25% and completed a rights offering that raised over $14 million in incremental capital.

Term
Q3 2026

“BayFirst is being transformed into the strong community bank that I've spoken about. ... While we still have work to do to deliver positive earnings in the short term, these accomplishments set the stage for that success. The earnings loss we report for the quarter is not indicative of what we will do going forward.”

Alfred T. Rogers, President, CEO & Director

“We are reporting a net loss of $677 thousand for the third quarter. This compares to the net loss of $32.7 million that we reported in the second quarter.”

Scott J. McKim, Executive VP & CFO
9:11 AM ET 8-K
Loan & Debt Indivior Pharmaceuticals, Inc. SUPN

Supernus Debt Financing Update with U.S. Bank Trust Company, National Association

Supernus, Inc. announced an adjustment to the conversion rate for its 0.625% Convertible Senior Notes due 2031 following a previously declared special dividend. The conversion rate increased from 24.0033 to 30.9355 shares per $1,000 principal amount, resulting in a new conversion price of approximately $32.33 per share.

Counterparty
U.S. Bank Trust Company, National Association
9:11 AM ET 10-Q
Financial Results Madrigal Pharmaceuticals, Inc. MDGL

Madrigal Pharmaceuticals Q3 2026 Results: Turns Profitable, Net Income $55.4M

Madrigal Pharmaceuticals reported a significant increase in net product revenue to $431.3 million for the third quarter of 2026, resulting in a quarterly net income of $55.4 million compared to a net loss in the prior year. For the nine months ended September 30, 2026, the company maintained a net loss of $96.9 million as it continues to scale commercial operations for Rezdiffra.

Key figure
Net income $55.4M
9:09 AM ET 8-K
Loan & Debt Geospace Technologies Corp GEOS

Geospace Technologies $25M Debt Financing with Amerisource Funding, Inc.

Geospace Technologies entered into a new $25 million revolving credit facility with Amerisource Funding, Inc. to refinance its existing debt and provide working capital. The new three-year agreement replaces a previous $25 million facility with Woodforest National Bank, which was terminated concurrently with the closing.

Value
$25M
Counterparty
Amerisource Funding, Inc.
Term
3 years
9:02 AM ET 10-Q
Financial Results Ichor Holdings, Ltd. ICHR

Ichor Holdings Q3 2026 Results: Turns Profitable, Net Income $20.9M

Ichor Holdings reported a significant recovery in the third quarter of 2026, with net sales increasing to $328.7 million compared to $239.3 million in the prior year period. The company achieved a net income of $20.9 million for the quarter, a substantial improvement from the $22.9 million net loss reported in Q3 2025, driven by higher gross margins and increased demand.

Key figure
Net income $20.9M
9:01 AM ET 8-K
Contract Win Cenntro Inc. CENN

Cenntro Wins $2.44M Contract from New York Truck Voucher Incentive Program

Cenntro Inc. delivered 20 LS450 electric trucks under the New York Truck Voucher Incentive Program (NYTVIP), generating over $2.44 million in revenue. The company is also expanding its participation in other state-level incentive programs in California and New Jersey to drive further adoption of its commercial electric vehicles.

Value
$2.44M
Counterparty
New York Truck Voucher Incentive Program (NYTVIP)
9:01 AM ET 10-Q
Financial Results Talen Energy Corp TLN

Talen Energy Q3 2026 Results: Net Income $138M, Down 33.3% YoY

Talen Energy reported a significant increase in operating revenues for the nine months ended September 30, 2026, reaching $3,203 million compared to $1,832 million in the prior year period. Despite higher revenues, net income attributable to stockholders decreased to $109 million from $144 million year-over-year, primarily driven by higher energy expenses and a $507 million unrealized loss on derivative instruments.

Key figure
Net income $138M · -33.3% YoY
9:01 AM ET 8-K
Stock Buyback PTC Therapeutics, Inc. PTCT

PTC Therapeutics Announces $500M Stock Buyback

PTC Therapeutics announced that its Board of Directors has authorized a share repurchase program to buy back up to $500 million of its common stock. The repurchases will be conducted at management's discretion through open-market or privately negotiated transactions based on market conditions.

Value
$500M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.